Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mojun Zhu

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
The Oncologist|June 9, 2020
Homologous Recombination Repair Defect May Predict Treatment Response to Peptide Receptor Radionuclide Therapy for Neuroendocrine TumorsMojun Zhu, Mohamad Bassam Sonbol, Thorvardur Halfdanarson, et al.
Targeted Oncology|December 10, 2025
Translational Relevance of the Genomic Landscape of KRAS<sup>G12D</sup>-Mutant Colorectal and Pancreatic CancersKhalid Jazieh, Jill Tsai, Sheila Solomon, et al.
Infection Control and Hospital Epidemiology|March 2, 2019
Antimicrobial therapy for asymptomatic bacteriuria or candiduria in advanced cancer patients transitioning to comfort measuresRupak Datta, Tianyun Wang, Mojun Zhu, et al.
Pancreas|January 18, 2022
Phase II Trial of Bevacizumab Monotherapy in Pancreatic Neuroendocrine TumorsMojun Zhu, Brian A Costello, Jun Yin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 3, 2025
Identification of Candidate Alterations Mediating KRASG12C Inhibitor Resistance in Advanced Colorectal and Pancreatic CancersKhalid Jazieh, Jill Tsai, Sheila Solomon, et al.
Cancer|February 11, 2025
Comparison of survival outcomes for patients with Lynch vs non-Lynch syndrome and microsatellite unstable colorectal cancer treated with immunotherapyCody Eslinger, Daniel Walden, Alyssa McGary, et al.
Cancer Metastasis Reviews|August 29, 2021
The role of microbiome in pancreatic cancerJenny Jing Li, Mojun Zhu, Purna C Kashyap, et al.
Investigational New Drugs|April 25, 2020
A phase I study of the VEGFR kinase inhibitor vatalanib in combination with the mTOR inhibitor, everolimus, in patients with advanced solid tumorsMojun Zhu, Julian R Molina, Grace K Dy, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|November 29, 2023
Microfluidic Organoid Cultures Derived from Pancreatic Cancer Biopsies for Personalized Testing of Chemotherapy and ImmunotherapyDaheui Choi, Alan M Gonzalez-Suarez, Mihai G Dumbrava, et al.
Cancers|December 23, 2023
Plasma Assay of Cell-Free Methylated DNA Markers of Colorectal Cancer: A Tumor-Agnostic Approach to Monitor Recurrence and Response to Anticancer TherapiesMojun Zhu, William R Taylor, Douglas W Mahoney, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
The Oncologist|June 9, 2020
Homologous Recombination Repair Defect May Predict Treatment Response to Peptide Receptor Radionuclide Therapy for Neuroendocrine TumorsMojun Zhu, Mohamad Bassam Sonbol, Thorvardur Halfdanarson, et al.
Targeted Oncology|December 10, 2025
Translational Relevance of the Genomic Landscape of KRAS<sup>G12D</sup>-Mutant Colorectal and Pancreatic CancersKhalid Jazieh, Jill Tsai, Sheila Solomon, et al.
Infection Control and Hospital Epidemiology|March 2, 2019
Antimicrobial therapy for asymptomatic bacteriuria or candiduria in advanced cancer patients transitioning to comfort measuresRupak Datta, Tianyun Wang, Mojun Zhu, et al.
Pancreas|January 18, 2022
Phase II Trial of Bevacizumab Monotherapy in Pancreatic Neuroendocrine TumorsMojun Zhu, Brian A Costello, Jun Yin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 3, 2025
Identification of Candidate Alterations Mediating KRASG12C Inhibitor Resistance in Advanced Colorectal and Pancreatic CancersKhalid Jazieh, Jill Tsai, Sheila Solomon, et al.
Cancer|February 11, 2025
Comparison of survival outcomes for patients with Lynch vs non-Lynch syndrome and microsatellite unstable colorectal cancer treated with immunotherapyCody Eslinger, Daniel Walden, Alyssa McGary, et al.
Cancer Metastasis Reviews|August 29, 2021
The role of microbiome in pancreatic cancerJenny Jing Li, Mojun Zhu, Purna C Kashyap, et al.
Investigational New Drugs|April 25, 2020
A phase I study of the VEGFR kinase inhibitor vatalanib in combination with the mTOR inhibitor, everolimus, in patients with advanced solid tumorsMojun Zhu, Julian R Molina, Grace K Dy, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|November 29, 2023
Microfluidic Organoid Cultures Derived from Pancreatic Cancer Biopsies for Personalized Testing of Chemotherapy and ImmunotherapyDaheui Choi, Alan M Gonzalez-Suarez, Mihai G Dumbrava, et al.
Cancers|December 23, 2023
Plasma Assay of Cell-Free Methylated DNA Markers of Colorectal Cancer: A Tumor-Agnostic Approach to Monitor Recurrence and Response to Anticancer TherapiesMojun Zhu, William R Taylor, Douglas W Mahoney, et al.
Pageof 3